A study looking at an intestinal microbiota transplant before a donor stem cell transplant for blood cancer (MAST)

Cancer type:

Acute leukaemia
Acute lymphoblastic leukaemia (ALL)
Acute myeloid leukaemia (AML)
Blood cancers
Chronic leukaemia
Chronic myeloid leukaemia (CML)
Myelodysplastic syndrome (MDS)

Status:

Open

Phase:

Phase 2

This study is looking at a type of treatment called intestinal microbiota transplant. It’s a way of encouraging more variety in gut bacteria.

It’s open to people having a bone marrow or stem cell transplant Open a glossary item with donor cells for:

  • acute myeloid leukaemia (AML)
  • acute lymphoid leukaemia (ALL)
  • acute leukaemia of ambiguous lineage
  • myelodysplastic syndrome (MDS)
  • chronic myelomonocytic leukaemia (CMML)
  • chronic myeloid leukaemia (CML)

More about this trial

Research has shown there are billions of ‘good’ bacteria and other microbes, such as viruses and fungi, living in our digestive system. This is also called the gut microbiome Open a glossary item.          

We know that bacteria in the microbiome helps to:

  • digest our food
  • protect against other bacteria in the digestive system which can cause disease
  • control our immune system Open a glossary item

People living with blood cancers often have antibiotics Open a glossary item a number of times due to their increased risk of infection. Antibiotics can reduce the number of ‘good’ bacteria in the digestive system leading to reduced variety in the microbiome.

You might have a bone marrow or stem cell transplant using donor cells for some types of blood cancer. It’s also called an allogeneic haematopoietic cell transplant (HCT). 

HCT is a treatment to try and get rid of the cancer completely. It also weakens your immune system, so it doesn’t work as well. This means that you are more likely to get infections or find it difficult to get rid of them.

Researchers want to bring back the number and range of ‘good’ bacteria for people having these treatments. They think this might help to support your immune system to work better. They think a treatment called intestinal microbiota transplant (IMT) could help. But they aren’t sure. They are doing this study to try and find out.

For an IMT, scientists take bacteria from healthy people’s digestive systems. They do this by taking a sample of poo (stool). They process it in the laboratory to separate the bacteria and put it into capsules. You take the capsules by mouth. And the microbes are released into your digestive system.

 The main aims of the study are to find out:

  • more about the benefits and side effects of an IMT
  • if an intestinal microbiota transplant can increase the range of ‘good’ microbes in people having a HCT using donor stem cells
  • how well the HCT works for people after an intestinal microbiota transplant when compared to a dummy drug (placebo Open a glossary item)
  • about the quality of life Open a glossary item of the people taking part

Who can enter

The following bullet points are a summary of the entry conditions for this study. Talk to your doctor or the study team if you are unsure about any of these. They will be able to advise you. 

Who can take part
You may be able to take part if you have one of the following:

Ask your doctor any questions you have around your risk group. They can explain what this means for you in terms of joining the study.

And if all of the following apply. You:

  • are well enough to have a bone marrow transplant or stem cell transplant (HCT) using stem cells from a donor (allogeneic transplant)
  • have had at least two cycles Open a glossary item of intensive chemotherapy before joining the study
  • have had certain antibiotics which act against many types of bacteria in the 3 months before joining the study. These are called broad spectrum antibiotics, and your doctor will know which ones they are.
  • can mostly care for yourself but you may need help from time to time (Karnofsky performance status 60 or above)
  • are willing to use reliable contraception during treatment and for 6 months afterwards if there is any chance that you or your partner could become pregnant
  • are aged 18 or over

Who can’t take part

Cancer related
You cannot join this study if any of these apply. You:

  • have another type of cancer at the moment
  • have had another type of cancer in the past. You might be able to take part if you have had lobular carcinoma in situ (LCIS), have had basal cell Open a glossary item or squamous cell skin cancer Open a glossary item that has been fully removed, very early cervical cancer (in situ) that has been treated or early stage prostate cancer which is too small to be seen on a scan (this is T1a or T1b prostate cancer). You might be able to take part if you have had MDS, CMML or a myeloproliferative neoplasm (MPM) which has changed into AML. You might also be able to take part if you have had another cancer and had treatment to get rid of the cancer completely more than 5 years ago.
  • are not able to safely have a bone marrow or stem cell transplant. Your doctor can explain more.

Medical conditions
You cannot join this study if any of these apply. You:

  • have serious kidney or liver problems. Your doctor can explain more.
  • have an active infection, HIV, long term active hepatitis B or hepatitis C
  • have swallowing problems that mean taking capsules might be difficult
  • have digestive system problems such as food passing through the stomach more slowly than it should, coeliac disease Open a glossary item, cystic fibrosis, inflammatory bowel disease, long term diarrhoea Open a glossary item or either an abnormal hole or tunnel in the bowel
  • have an autoimmune disease Open a glossary item and are having, or might need, treatment with steroids or any other medicine that affects the immune system 
  • have a serious bleeding problem. You can still take part if you have had significant bleeding because of your blood cancer.
  • have low blood pressure needing a type of medicine called a vasopressor 
  • have heart problems Open a glossary item called valvular heart disease or you have changes to the structure of your heart

Other
You cannot join this study if any of these apply. You:

  • have had another microbiota transplant within the 3 months before joining the study
  • have taken probiotics after joining the study
  • have a very serious food allergy (anaphylaxis)
  • are allergic to anything the treatment capsule contains
  • are pregnant or breastfeeding

Trial design

This phase 2a study is taking place in the UK. The researchers need around 50 people to take part.

It is a randomised double blind study. You are put into a group by a computer. Neither you nor your doctor will be able to decide which group you are in. Nor will you or your doctor know which treatment you have. During the study your doctor will be able to find out what treatment you are having, if necessary.

There are 2 treatment groups. You have 1 of the following:

  • intestinal microbiota transplant
  • dummy drug (placebo)

Intestinal microbiota transplant
You have the intestinal microbiota transplant as capsules by mouth

You take 10 capsules with water and will be given plenty of time to swallow them. 

The picture below shows what the capsules look like:

Dummy drug (placebo)
You have 10 capsules which look like the intestinal microbiota transplant capsules. But they don’t have any medicine or microbes inside.

You take the 10 capsules with water and will be given plenty of time to swallow them.

Both groups
You have your capsules around 2 weeks before your stem cell infusion.

You have your HCT as part of your usual care. It’s not part of the study. Your HCT team will explain everything to you. This includes any possible side effects and how long you might stay in hospital. Ask them any questions you have.

Samples for research
You have tests for research before and after your HCT.

These are:

  • blood tests at the hospital
  • poo samples – you can bring a sample from home or do your sample in the hospital 
  • urine tests – try and collect your first wee of the morning

The researchers use these samples to look at:

  • possible blood biomarkers Open a glossary item
  • any changes in the microbes in your poo before and after the intestinal microbiota transplant
  • changes in substances in your wee related to the digestive microbiome before and after the intestinal microbiota transplant

Quality of life
The study team ask you to fill out some questionnaires: 

  • before you have treatment
  • at set times during your HCT care
  • at set times during follow-up 

The questionnaires ask about side effects and how you’ve been feeling. This is called a quality of life study.

After HCT
The study team look at your medical notes during the study to look at how you’re getting on after your HCT. This includes:

  • if you’ve had any fevers
  • if you’ve had any infections
  • any other side effects you’ve had from your HCT
  • what treatments you’ve been having
  • what has happened to your blood cancer after your HCT

Hospital visits

You see the doctor and have some tests before you can take part. These include:

  • a physical examination Open a glossary item
  • blood tests
  • urine tests
  • poo sample – you can bring a poo sample the next time you come to hospital if you’re not able to collect a sample at this visit
  • pregnancy test – if there is any chance you could become pregnant

You go to the hospital around 2 weeks before your stem cell infusion. 

You have:

  • either the intestinal microbiota transplant capsules or the dummy drug
  • blood tests

A week later you go back to the hospital to see the study team and have:

  • blood tests
  • poo tests
  • urine tests

Around a week later you have your HCT.

You see the study team and have blood, urine and poo tests on the day of your bone marrow or stem cell transplant. And then at certain points after your HCT. These are at:

  • 1 week after your stem cell infusion
  • 2 weeks after your stem cell infusion
  • 3 weeks after your stem cell infusion

Follow up
The study team see how you are getting on after your HCT. This is at:

  • around 3 months after your stem cell infusion
  • around 7 months after your stem cell infusion
  • around a year after your stem cell infusion

Diary
You fill in a diary card each day about any side effects that you have. You do this for 2 weeks after the intestinal microbiota transplant. You go through it with the study team at your next visit. There’s a number to call in the diary if you are having problems filling it in.

Questionnaire about diet
At each visit you fill in a questionnaire about what you have been eating during the day of your tests. This is because some foods, such as fish and liquorice, can affect the results of your samples.

You don’t need to change your diet to take part in this study.

Side effects

The study team monitor you during treatment and afterwards. Contact your advice line or tell your doctor or nurse if any side effects are bad or not getting better. 

There are some risks involved with having the microbiota transplant. But these are not common. They are:

  • feeling or being sick
  • bloating
  • constipation Open a glossary item

They should get better after a couple of days.

There is a low risk of infection from the microbiota transplant itself. All the donors are tested to try and prevent this from happening.

We have more information about:

Location

Birmingham
Leeds
London

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Dr Jiri Pavlu
Professor Julian Marchesi

Supported by

Imperial College London
Medical Research Council (MRC)

If you have questions about the trial please contact our cancer information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

19681

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think